Interferon-α-Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV Infections

Table 1

Clinical features classified by the SVR status of chronic hepatitis C patients with genotype 1.

Sex	Age; (yr)	ALT; (IU/L)	g-GTP; (IU/L)	Plt; (10^9/L)	IL-28B; (rs8099917)	Response
M	59	63	33	20	TT	SVR
M	50	31	31	20.2	TT	SVR
M	69	35	27	17.3	TT	SVR
M	31	61	25	18.5	TT	SVR
F	69	125	157	16.3	TT	SVR
M	55	66	132	18.4	TT	SVR
M	67	119	61	20.2	TG	SVR
F	52	178	101	16.1	TG	SVR
F	37	45	65	18.7	TT	NR
F	43	65	128	13.4	TT	NR
M	29	79	147	20.2	TG	NR
F	68	76	76	7.9	TG	NR
M	43	112	62	18.2	TT	PR
M	51	84	59	17.7	TT	PR
F	38	31	30	20.1	TT	PR
F	63	72	33	15.9	TT	PR
M	62	44	48	12.2	TG	PR
M	66	38	52	11.8	TG	PR
M	54	50	32	18.8	TG	PR
F	60	77	43	13.8	GG	PR